Heterocyclic dihydroanthracen imines

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260250AC, 2602564F, 2602565R, 260283SC, 260283S, 260287B, 260288CF, 260325R, 2603261, 424250, 424251, 424273R, 548304, 548326, 548305, 548306, 548323, C07D47108, A61K 31395, C07D48708

Patent

active

040525082

ABSTRACT:
Heterocyclic dihydroanthracen imines are disclosed to be useful as minor tranquilizers, anticonvulsants, muscle relaxants and to be useful in the treatment of extrapyramidal disorders such as Parkinson's disease; also disclosed are processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions.

REFERENCES:
patent: 3678072 (1972-07-01), Klanderman et al.
Wittig et al., Annelen, vol. 630, pp. 10-18 (1960).
BoVaris et al., J. Chem. Soc. Chem. Comm., vol. 1974, p. 870.
Heaney et al., Chem. Abstr., vol. 77, col. 164364n (1972).
Kricha et al., J. Chem. Soc. Perkin I, vol. 1973 pp. 766-771.
Emmet et al., Tetrahedron, vol. 22, pp. 1011-1018 (1966).
Harrison et al., Tetrahedron, vol. 24, pp. 4589-4594 (1968).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic dihydroanthracen imines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic dihydroanthracen imines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic dihydroanthracen imines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1775516

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.